ResMed Inc.RMD
NYSE•Healthcare•Medical Instruments & Supplies
Analyze revenue and earnings growth — the core drivers of long-term shareholder returns.
TTM revenue reached $5.54B, growing 10.3% year-over-year. TTM net income stood at $1.52B (15.7% growth). Quarterly EBITDA was $558.79M and operating income was $499.81M. Consistent revenue and earnings growth are the primary drivers of long-term shareholder returns. Analyze RMD growth trends across revenue, EBITDA, operating income, and net income.
Revenue and earnings growth across quarters